Experimental angiotensin II hypertension

Area of Science:

• Cardiovascular Physiology
• Renal Physiology
• Hypertension Research

Background:

• Angiotensin II (AII) is a key hormone implicated in blood pressure regulation.
• Understanding the mechanisms of AII-induced hypertension is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the hemodynamic and volume changes associated with AII-induced hypertension in dogs.
• To elucidate the role of vascular tone and circulatory compliance in this hypertensive model.

Main Methods:

• Infusion of Angiotensin II (AII) at 10 ng x kg-1 x min-1 intravenously for 8 days in 13 large dogs.
• Monitoring of arterial pressure, cardiac output, mean circulatory filling pressure (MCFP), and sodium balance.
• Assessment of 22Na space and blood volume throughout the study.

Main Results:

• AII infusion significantly increased arterial pressure and mean circulatory filling pressure (MCFP).
• Cardiac output decreased, while blood volume remained unchanged.
• Initial sodium retention was followed by natriuresis, returning dogs to sodium balance.
• A decrease in circulatory unstressed volume or compliance was inferred.

Conclusions:

• AII-induced hypertension in this model is characterized by increased arterial and venous vascular tone.
• The rise in blood pressure occurs without significant volume expansion or cardiac output elevation.
• Altered circulatory compliance plays a critical role in the development of AII-hypertension.